Spatial context is fundamental to understanding tissue organization, health and disease, yet traditional dissociative methods can miss how a cell’s location, neighboring cells and local signaling environment shape function. This webinar explores how researchers can preserve spatial context while moving from unbiased biomarker discovery to targeted spatial proteomic analysis using customizable panels.
Preserving spatial context, however, is only part of the equation. Researchers also need the flexibility to move from unbiased discovery to targeted analysis, customizing spatial biomarker panels as new biological insights emerge. Next-generation molecular barcoding technology can enable researchers to barcode antibodies of interest and design high- and low-plex proteomic panels tailored to specific research questions.
In this webinar, the featured speakers will explore the principles of next-generation molecular barcoding, discuss its advantages for spatial proteomics and demonstrate strategies for designing and customizing biomarker panels, including how a molecular barcoding kit supports a simplified workflow.
Register for this webinar to learn how biomarker discovery can be translated into customizable spatial proteomic panels and spatial signatures.
Speakers
Antoinette Ronquillo, MS, Senior Field Application Scientist, Quanterix®
Antoinette brings more than six years of experience in spatial proteomics, including hands-on experience with the Akoya PhenoCycler-Fusion, PhenoImager HT and other legacy platforms. She supports advanced spatial biology technologies across dozens of academic, biopharma and CRO accounts throughout Western North America. With deep expertise in multiplex immunofluorescence assay development, tissue-based imaging and antibody-based spatial workflows, she leads instrument trainings, technical seminars and early-access programs that accelerate the adoption of cutting-edge spatial platforms.
Message Presenter
Clemens Duerrschmid, PhD, Senior Manager, Field Applications, Quanterix®
Dr. Clemens Duerrschmid is a biotechnology professional with expertise in imaging, single-cell biology and spatial proteomics. He currently leads the Field Applications Scientist team at Quanterix, where he focuses on technical strategy, customer education and adoption of spatial biology and immunoassay platforms.
With more than a decade of experience spanning academia, biotech and pharma, Clemens has supported scientific discovery through technology and collaboration. Prior to Quanterix, he held leadership and customer-facing roles at Akoya Biosciences, where he worked with key opinion leaders, represented spatial biology at seminars and conference presentations and supported researchers across multiple fields. His earlier research career included developing immunoassays and studying metabolic disease therapeutics as a Postdoctoral Fellow at Baylor College of Medicine and Case Western Reserve University.
Clemens holds a PhD in Biotechnology from BOKU University in Vienna, Austria. He is committed to helping researchers advance discovery in spatial biology and liquid biomarker research.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Researchers across discovery
- Translational Scientists
- Clinical settings already using spatial biology technologies — including proteomics, transcriptomics and immunofluorescence (IF) – as well as those looking to expand into high-plex spatial proteomics and molecular barcoding workflows
What You Will Learn
Attendees will gain insights into:
- The differences between next-generation molecular barcoding and other antibody conjugation methods
- Designing new biomarker panels or expanding off-the-shelf panels using a streamlined, reproducible workflow
- How molecular barcoding supports multimodal spatial analysis by integrating high-plex proteomics with transcriptomics
Xtalks Partner
Quanterix
Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company®, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,396 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics. Learn more at www.quanterix.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account